Rebalix
Logo AmundiAmundi · sheet of 4 September 2026
ETF sheet · official issuer and register data

Amundi MSCI All Country World UCITS ETF USD Acc

ACWL · LU1829220133 · class UCITS ETF USD Acc · USD · domicile Luxembourg
Equity · GlobalSFDR art. 6
Index tracked: MSCI ACWI Net Total Return USD Index
TER
0.45%+ trans. 0.00%
Fund size
126 m EUR
Tracking difference
−0.16%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Synthetic (swap)
Income
Accumulating
Launch 8 Nov 2018 · costs from the KID as of 2 Sept 2026 · 132 securities held · 5 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 7 Aug 2026
The Fund is an index-tracking UCITS passively managed. The investment objective of the Fund is to track both the upward and the downward evolution of the MSCI AC World Index (ACWI) Net Total Return" (the "Benchmark Index"),denominated in US Dollars (USD), and representative of equity markets in developed and emerging market countries, while minimizing the volatility of the difference between the return of the Fund and the return of the Benchmark Index (the "Tracking Error"). The anticipated level of tracking error in normal market conditions is indicated…

Performance since series start (in euro) — base 100

3 Oct 20123 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
201320152017201920212023202548597484
High 485 (17 Aug 2026) · low 97 (16 Nov 2012) · last 484. Past performance is not indicative of future results.

Returns in euro

1 year+23.9%
3 years+63.1%
5 years+69.5%
10 years+208.6%
Since series start+383.6%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.48%12.09%13.78%
Max drawdown−9.31%−16.09%−26.45%
Sharpe1.661.320.62
Sortino2.481.890.88
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · ACWL · LU18292201331
RebalixACWL · LU1829220133 · sheet of 4 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+22.13%+22.34%−0.20%
2024+17.35%+17.49%−0.13%
2023+22.04%+22.20%−0.16%
2022−18.49%−18.36%−0.13%
2021+18.35%+18.54%−0.19%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 132 securities · top-10 weight = 56.9%
Top holdingsWeight
APPLE INC9.2%
NVIDIA CORP8.7%
AMAZON.COM INC8.6%
META PLATFORMS INC-CLASS A6.9%
WALMART INC4.6%
JPMORGAN CHASE & CO4.3%
RTX CORP4.1%
BERKSHIRE HATHAWAY INC-CL B4.0%
TESLA INC3.6%
MICRON TECHNOLOGY INC3.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
LYAC · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Tradegate Exchange
+ 6 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU1829220133/ENG/LUX
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU1829220133/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU1829220133/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU1829220133
Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · ACWL · LU18292201332